These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30541017)

  • 1. Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases.
    Ostrowski J; Dabrowska M; Lazowska I; Paziewska A; Balabas A; Kluska A; Kulecka M; Karczmarski J; Ambrozkiewicz F; Piatkowska M; Goryca K; Zeber-Lubecka N; Kierkus J; Socha P; Lodyga M; Klopocka M; Iwanczak B; Bak-Drabik K; Walkowiak J; Radwan P; Grzybowska-Chlebowczyk U; Korczowski B; Starzynska T; Mikula M
    J Crohns Colitis; 2019 Apr; 13(5):626-633. PubMed ID: 30541017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
    Heydari R; Fayazzadeh S; Shahrokh S; Shekari F; Farsad F; Meyfour A
    Inflamm Bowel Dis; 2024 May; 30(5):795-807. PubMed ID: 37855715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.
    Chen P; Li Y; Li L; Yu Q; Chao K; Zhou G; Qiu Y; Feng R; Huang S; He Y; Chen B; Chen M; Zeng Z; Zhang S
    Aliment Pharmacol Ther; 2019 Mar; 49(6):733-743. PubMed ID: 30734320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease Pathogenesis.
    McDermott E; Ryan EJ; Tosetto M; Gibson D; Burrage J; Keegan D; Byrne K; Crowe E; Sexton G; Malone K; Harris RA; Kellermayer R; Mill J; Cullen G; Doherty GA; Mulcahy H; Murphy TM
    J Crohns Colitis; 2016 Jan; 10(1):77-86. PubMed ID: 26419460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease.
    Kalla R; Adams AT; Ventham NT; Kennedy NA; White R; Clarke C; Ivens A; Bergemalm D; Vatn S; Lopez-Jimena B; ; Ricanek P; Vatn MH; Söderholm JD; Gomollón F; Nowak JK; Jahnsen J; Halfvarson J; McTaggart S; Ho GT; Buck A; Satsangi J
    J Crohns Colitis; 2020 Dec; 14(12):1724-1733. PubMed ID: 32598439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases.
    Ostrowski J; Goryca K; Lazowska I; Rogowska A; Paziewska A; Dabrowska M; Ambrozkiewicz F; Karczmarski J; Balabas A; Kluska A; Piatkowska M; Zeber-Lubecka N; Kulecka M; Habior A; Mikula M; ;
    Sci Rep; 2019 May; 9(1):7190. PubMed ID: 31076612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease.
    Hübenthal M; Hemmrich-Stanisak G; Degenhardt F; Szymczak S; Du Z; Elsharawy A; Keller A; Schreiber S; Franke A
    PLoS One; 2015; 10(10):e0140155. PubMed ID: 26466382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
    Miranda-García P; Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2016 Oct; 39(8):508-15. PubMed ID: 27020243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
    Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
    Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
    Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
    Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.
    Wilson A; Teft WA; Morse BL; Choi YH; Woolsey S; DeGorter MK; Hegele RA; Tirona RG; Kim RB
    Dig Dis Sci; 2015 Dec; 60(12):3620-30. PubMed ID: 26160437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
    Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
    World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
    Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription and DNA Methylation Patterns of Blood-Derived CD8
    Gasparetto M; Payne F; Nayak K; Kraiczy J; Glemas C; Philip-McKenzie Y; Ross A; Edgar RD; Zerbino DR; Salvestrini C; Torrente F; Ventham NT; Kalla R; Satsangi J; Sarkies P; Heuschkel R; Zilbauer M
    Gastroenterology; 2021 Jan; 160(1):232-244.e7. PubMed ID: 32814113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of elafin in peripheral blood in inflammatory bowel disease patients and its clinical significance].
    Zhang W; Teng GG; Tian Y; Wang HH
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1120-3. PubMed ID: 27095781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.
    de Meij TGJ; de Groot EFJ; Peeters CFW; de Boer NKH; Kneepkens CMF; Eck A; Benninga MA; Savelkoul PHM; van Bodegraven AA; Budding AE
    PLoS One; 2018; 13(8):e0197649. PubMed ID: 30102706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.